COSMETIC OR PHARMACEUTICAL COMPOSITION FOR SKIN TAUTENING, SKIN FIXATION AND WRINKLE REDUCTION

VIBRIO CHOLERAE PROTEIN FOR USE AGAINST CANCER

PDK4 as a Cell-Aging Intervention Target and Its Use in Chemotherapy and Anticancer

PROTEIN PHOSPHATASE 2A ACTIVATORS

NUCLEOPHILIC CHEMICALS USEFUL IN THE TREATMENT OF CISPLATIN-INDUCED SENSORY NEUROPATHY AND OTOTOXICITY

COMBINATION TREATMENT OF AN ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY AND CHEMOTHERAPY

CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION

TREATMENT OF ONCOGENE-DRIVEN CANCERS

AZOLE DERIVATIVES AS SHP2 INHIBITORS

PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER

METHODS AND SYSTEMS FOR IMPROVING ANTI-CANCER THERAPIES

COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION

COMBINATION THERAPIES COMPRISING PANOBINOSTAT FOR THE TREATMENT OF CHOLANGIOCARCINOMA

ANTI-FGFR2 ANTIBODIES IN COMBINATION WITH CHEMOTHERAPY AGENTS IN CANCER TREATMENT

METHODS OF TREATING NON-SMALL CELL LUNG CANCER WITH ANTI-PD-1-ANTIBODIES

METHODS OF TREATING CANCER WITH AN ANTI-PD-L1 ANTIBODY

COMBINATION THERAPY

IL-12 GENE THERAPY AND ANTI-VEGF COMBINATION FOR TREATING CANCER

BRUSH PRODRUGS AND USES THEREOF

METHOD OF TREATING CANCER

PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER

CXCR4 ANTAGONIST LOADED LIPOSOMES AND SILICASOMES

PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER

TREATING PANCREATIC CANCER

GAMMA POLYGLUTAMATED METHOTREXATE AND USES THEREOF

COMBINATION THERAPY FOR A RAS RELATED DISEASE OR DISORDER

ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF

VACCINE ADJUVANTS AND FORMULATIONS

COMBINATION THERAPY WITH NEOANTIGEN VACCINE

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

COMBINATION THERAPY FOR LUNG CANCER

Dosing Regimen for Therapies Comprising Bispecific Anti-EGFR/C-Met Antibodes

Compositions and Methods for Treating Cancer

METHODS FOR LIPID NANOPARTICLE DELIVERY OF CRISPR/CAS SYSTEM

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

QUINOLINE DERIVATIVE USED FOR TREATING SMALL CELL LUNG CANCER

EZH1/2 DUAL INHIBITOR-CONTAINING PHARMACEUTICAL COMPOSITION TO BE USED AS A COMBINATION DRUG

METHODS FOR TREATING TUMORS

STABILIZED COMPOSITIONS COMPRISING CANNABIDIOL

STING AGONIST-CONTAINING UREASE-POWERED NANOMOTOR-BASED BLADDER CANCER IMMUNOTHERAPY AGENT

METHODS OF TREATING CANCER WITH ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES

METHOD FOR PRETREATING RELAPSING CANCER

METHODS OF TREATING CANCER BY INHIBITING BACTERIAL DNAK TO RESTORE ACTIVITIES OF ANTICANCER DRUGS

COMPOSITION FOR THE INHIBITION OF NRF2 AND USES THEREOF IN CANCER THERAPY

COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING LIPID NANOPARTICLES

INTERFERON-BASED CANCER TREATMENT METHOD, AND PHARMACEUTICAL COMBINATION

TREATMENT OF CANCER USING ARIPIPRAZOLE AND ANTICANCER AGENT

DOSING REGIMENS FOR TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA

SYSTEMS AND METHODS FOR TREATING CANCER

METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER

COMBINATION USES OF NITROXOLINE AND ITS ANALOGUES WITH CHEMOTHERAPIES AND IMMUNOTHERAPIES IN THE TREATMENT OF CANCERS

Cancer Treatments Using MTA-Cooperative PRMT5 Inhibitors

GAMMA POLYGLUTAMATED METHOTREXATE AND USES THEREOF

METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY

ERCC1-XPF COMPLEX INHIBITOR COMPOUNDS AND THE USE THEREOF IN THE TREATMENT OF CANCER

GAMMA POLYGLUTAMATED RALTITREXED AND USES THEREOF

COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE

METHODS OF TREATING BREAST CANCER

POLYMER-COATED NANOPARTICLES AND PREPARATION METHOD THEREFOR

METHODS OF TREATING ENDOMETRIAL CANCER USING HEMP EXTRACT

USE OF AMISULPRIDE AS AN ANTI-EMETIC

EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE

METHODS FOR TREATING CANCER PATIENTS WITH HOMOLOGOUS RECOMBINATION DEFICIENCY BASED ON TEMPLATED INSERTIONS

COMBINATION THERAPY FOR TREATMENT OF DISEASE

ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF OVARIAN CANCER

PLATINUM-BASED AMPHIPHILE PRODRUGS

MULTISPECIFIC ANTIBODIES FOR TREATING CD47-ASSOCIATED DISEASES

ARTICLE FOR USE WITH AN APPARATUS FOR HEATING AN AEROSOL GENERATING AGENT

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

PLATINUM-RESISTANT CANCER TREATMENT

ALBUMIN CONJUGATES AND RADIOPHARMACEUTICAL COMPOSITION THEREOF

iRGD-ANALOGS AND RELATED THERAPEUTIC METHODS

COMBINATION TREATMENT OF AN ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY AND CHEMOTHERAPY IN CTDNA HIGH RISK PATIENTS

COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER

COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO CISPLATIN

Combination Treatment Regimens - SMARCA2 Degrader With Gemcitabine

COMPOSITIONS AND METHODS FOR ENHANCING THE EFFECT OF PLATINUM-BASED SYSTEMIC THERAPY

TREATMENT OF GASTRIC CANCER AND/OR GASTROESOPHAGEAL JUNCTION CANCER

METHODS OF AND COMPOSITIONS FOR REDUCING GENE EXPRESSION AND/OR ACTIVITY

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

Treating Gastric Cancer Using TTFields Combined with XELOX, FOLFOX or the Individual Constituents Thereof

ALPHA POLYGLUTAMATED METHOTREXATE AND USES THEREOF

TREATING HAEMATOLOGICAL MALIGNANCIES BY MEANS OF SATRAPLATIN

PHARMACEUTICAL COMBINATIONS

USE OF PLINABULIN IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS

ADMINISTRATION OF AURORA KINASE INHIBITOR AND CHEMOTHERAPEUTIC AGENTS

METHOD FOR CANCER TREATMENT WITH A HYPERTHERMAL AGENT

Combined Use of Anti-TROP-2 Antibody-drug Conjugate and other Therapeutic Agents

TWO-STAGE MICROPARTICLE-BASED THERAPEUTIC DELIVERY SYSTEM AND METHOD

IMMUNE- STIMULATING COMPOUNDS LINKED TO GLYCOGEN-BASED POLYSACCHARIDE NANOPARTICLES FOR SENSITIZING CANCER CELLS TO A CHEMOTHERAPEUTIC DRUG

CANCER TREATMENT METHOD USING NANOMEDICINAL COMPOSITION

PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE

DRUG FOR TREATING AND/OR PREVENTING CANCER AND USE THEREOF

PERSONALIZED MODULATION THERAPY FOR CANCER

TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

COMBINATION THERAPY FOR TREATING LUNG CANCER

TREATMENT FOR CANCER

KRAS ANTAGONISTS

COMPOSITIONS AND METHODS FOR TREATMENT OF MIC60 DEPLETED CANCERS AND METASTASIS

COMBINATION THERAPIES FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER

METHODS FOR TREATMENT OF CANCER WITH AN ANTI-TIGIT ANTAGONIST ANTIBODY

APPLICATION OF RIP2 INHIBITOR COMBINED WITH CHEMOTHERAPY DRUG

LAG-3 ANTAGONIST THERAPY FOR LUNG CANCER

PHARMACOLOGIC MODULATION OF 5-FLUOROURACIL BY FOLINIC ACID AND VITAMIN B6 FOR THE TREATMENT OF PATIENTS WITH CARCINOMA

NOVEL SYNERGISTIC COMBINATIONS AND METHODS OF USE THEREOF FOR TREATING CANCERS

HYPOXIA INDUCIBLE FACTOR-2(ALPHA) INHIBITORS FOR THE TREATMENT OF BLADDER CANCER

METHODS OF TREATING CANCER AND THE PHARMACEUTICAL COMPOSITIONS THEREOF

METHODS OF TREATING CHEMOTHERAPY-RESISTANT CANCER WITH AN ANTIBODY-DRUG CONJUGATE

EZH2 Inhibition in Pancreatic Cancer

Method for hyperthermially treating a cancer

BAG6 SPECIFIC CHIMERIC ANTIGEN RECEPTOR, NUCLEIC ACID, BAG6 SPECIFIC CHIMERIC ANTIGEN RECEPTOR EXPRESSION PLASMID, BAG6 SPECIFIC CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELL, USE THEREOF, AND PHARMACEUTICAL COMPOSITION FOR TREATING CANCER

Triple Drug Combination (Metformin, Simvastatin, Digoxin) for Targeted Treatment of Colorectal Cancer

METHODS OF TREATING ESTROGEN SENSITIVE DISEASES WITH CANNABIS EXTRACT

METHODS AND COMPOSITIONS FOR TREATING CANCER

Compositions and Methods for Treating Inflammation Associated with IL-6

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

[6R]-MTHF IN B6 ENHANCED 5-FU BASED CHEMOTHERAPY OF CARCINOMA

[6R]-MTHF IN B6 ENHANCED 5-FU BASED CHEMOTHERAPY OF PANCREATIC CANCER

Pharmaceutical combination for the treatment of a cancer

IMMUNE MEMORY INDUCTION BY PLATINUM BASED COMPOUNDS

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

CO-CRYSTAL COMPOSITION AND ITS PHARMACEUTICAL USE

MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

METHODS OF REDUCING NEUROPATHY AND NEUROPATHIC SYMPTOMS AND TREATING CANCER

METHODS OF TREATING OVARIAN CANCER WITH HEMP EXTRACT

COMBINATION DRUG FOR TREATMENT OF GASTRIC CARCINOMA AND/OR ESOPHAGOGASTRIC JUNCTION CANCER

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

COMBINATION THERAPIES WITH SIRP ALPHA-BASED CHIMERIC PROTEINS

METHOD FOR TREATING CANCER WITH ACYLFULVENE AND RADIATION

Stabilized compositions comprising cannabidiol

COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO

EGFR INHIBITOR FOR THE TREATMENT OF HEAD AND NECK CANCER

TRIPLE COMBINATION THERAPY

NOVEL COMBINATORIAL ANTITUMOR TREATMENT METHODS AND RELATED COMPOSITIONS, KITS, AND SYSTEMS

RNA SIGNATURE OF PDAC SENSITIVITIES TO ANTICANCER TREATMENTS

COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO TYROSINE KINASE INHIBITORS

METHODS OF TREATING CANCERS HAVING A DEREGULATED NRF2/KEAP1 PATHWAY

BIODEGRADABLE MUCOADHESIVE PHARMACEUTICAL FORMULATIONS AND METHODS THEREOF

METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS

AXL COMPOUNDS

METHODS OF TREATING CANCER AND ISCHEMIA DISEASES BY INHIBITION AND INTERVENTION OF ATR PROLYL ISOMERIZATION

METHODS AND COMPOSITIONS FOR TREATING CANCER

COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND FOLFIRINOX

METHODS FOR OPTIMIZING THE TREATMENT OF COLORECTAL CANCER

PEPTIDES FOR THE TREATMENT OF CANCER

PALM FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY INCIDENTAL TO THE TREATMENT OF CANCER

METHODS TO ANALYZE HOST-MICROBIOME INTERACTIONS AT SINGLE-CELL AND ASSOCIATED GENE SIGNATURES IN CANCER

BCL-2 INHIBITORS

COMPOSITIONS AND METHODS FOR INHIBITING CREATINE TRANSPORT AS A TREATMENT FOR CANCER

METHODS FOR DECREASING RESISTANCE TO CHEMOTHERAPY

ALPHA POLYGLUTAMATED PEMETREXED AND USES THEREOF

ANTICANCER THERAPIES USING ANTI-CCR8 ANTIBODY, CHEMO AND IMMUNOTHERAPY COMBINATIONS

Stabilized compositions comprising cannabidiol

GLUTAMINASE INHIBITOR THERAPY

ANTISENSE OLIGONUCLEOTIDES FOR THEIR USE IN AN ANTI-CANCER TREATMENT

ANTI-ICOS ANTIBODIES

COMBINATIONS WITH AN ANTI HUMAN CD39 ANTIBODY, AN ANTI HUMAN PD-1 ANTIBODY, AND CHEMOTHERAPY IN GASTRIC CANCER

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH SUBCUTANEOUS ADMINISTRATION OF ANTI-PD1 ANTIBODIES

COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING THERAPY-RELATED CARDIOMYOPATHY ASSOCIATED WITH NEUTROPHIL INFILTRATION

Methods and compositions related to glucocorticoid receptor antagonists and breast cancer

COMPOSITION FOR TREATMENT OF ANTICANCER DRUG RESISTANCE

USE OF OREGOVOMAB AND BEVACIZUMAB, PACLITAXEL, CARBOPLATIN FOR TREATMENT OF BRCA-WILD TYPE PLATINUM SENSITIVE RECURRENT

Methods of treating estrogen sensitive diseases with cannabis extract

COMPOSITIONS AND METHODS FOR PARENTERAL ADMINISTRATION OF THERAPEUTIC AGENTS

Anticancer trail-targeted plant virus particles

Dosing Regimen for Therapies Comprising Bispecific Anti-EGFR/C-Met Antibodies

LAG-3 ANTAGONIST THERAPY FOR LUNG CANCER

Cancer treatment method for magnetic hypothermia cancer treatment

VIBRIO CHOLERAE PROTEIN FOR USE AGAINST CANCER

CONTROLLED DRUG RELEASE FORMULATION

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

COMBINATION THERAPIES FOR TREATING CANCER

COMBINATION THERAPY WITH FOR46 FOR CANCER

NOVEL MULTILAYER SUPPOSITORY AGENT

THERAPEUTIC AND DIAGNOSTIC METHODS AND COMPOSITIONS FOR CANCER

COMBINATION THERAPY USING AN ANTI-FUCOSYL-GM1 ANTIBODY

COMPOSITIONS AND METHODS FOR IMPROVED TREATMENT OF PLATINUM-BASED CHEMOTHERAPEUTIC RESISTANT TUMORS

ANTI-GARP-TGF-BETA1/PD-1 COMBINATION THERAPY

VACCINE ADJUVANTS AND FORMULATIONS

COMBINATION THERAPY FOR TREATING CANCER

TWO-STAGE MICROPARTICLE-BASED THERAPEUTIC DELIVERY SYSTEM AND METHOD

METHODS, KITS, AND SYSTEMS FOR PREDICTING PATIENT OUTCOMES

FUNCTIONALIZED AND CROSSLINKED POLYMERS

COMPOSITION CONTAINING WATER-SOLUBLE DRUG CAUSING VASCULAR DISORDER, SOLUTION FOR USE IN PREPARATION OF ADMINISTRATION SOLUTION CONTAINING WATER-SOLUBLE DRUG CAUSING VASCULAR DISORDER, KIT, AGENT FOR SUPPRESSING VASCULAR DISORDER, AND SOLUTION CONTAINING NONIONIC SURFACTANT

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER

THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING PANCREATIC CANCER USING DEVIMISTAT

METHODS FOR TREATMENT OF CANCER AND PHAGOCYTOSIS-DEFICIENCY RELATED DISEASES

PT(IV) CHEMOTHERAPEUTIC PRODRUG AND CONTROLLED RELEASE THEREOF FOR TREATMENT OF TUMORS

METHODS AND KITS FOR DIAGNOSING AND TREATING CANCERS

Methods of treating endometrial cancer using hemp extract

COMBINATION TREATMENT OF AN ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY AND CHEMOTHERAPY

Methods of treating ovarian cancer with hemp extract

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER

SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY

Method for treating breast cancer

LUNG CANCER COMBINATION THERAPY WITH IL-2 CONJUGATES AND AN ANTI-PD-1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF

Combination Therapy Comprising an AXL Inhibitor

COMBINATION THERAPY FOR TREATING COLORECTAL CANCER

BISPECIFIC ANTIBODY AGAINST CD3 AND CD20 IN COMBINATION THERAPY FOR TREATING DIFFUSE LARGE B-CELL LYMPHOMA

THERAPEUTIC AGENT FOR MALIGNANT MESOTHELIOMA AND METHOD FOR SELECTING PATIENT HAVING MALIGNANT MESOTHELIOMA

Exosomal compositions and methods for the treatment of disease

DNA Damage Repair Deficit in Cancer Cells

Porous silicate and/or aluminosilicate matrix/cerium oxide nanoparticle nanocarrier for combination anti-cancer therapeutic and antioxidant delivery

Myokines for treating cell proliferative and metabolic diseases and disorders

METHODS OF TREATING CANCER USING A COMBINATION OF A PD-1 ANTAGONIST, A CHEMORADIATION THERAPY AND A PARP INHIBITOR

METHOD OF TREATING CANCER

METHODS AND COMPOSITIONS FOR NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY

Antibodies and methods for making and using the same

SATRAPLATIN FOR USE IN THE TREATMENT OF LYMPHOID NEOPLASMS

METHOD FOR TREATING A GD2-POSITIVE CANCER

COMPOSITIONS AND METHODS FOR INHIBITING CARP-1 BINDING TO NEMO

USE OF APE1/REF-1 INHIBITORS FOR TREATMENT OF RETINAL DISEASES

COMBINED USE OF ANTI-CCR8 ANTIBODY AND CHEMOTHERAPEUTIC AGENT

COMBINATION THERAPY WITH A MUTANT IDH1 INHIBITOR, A DEOXYADENOSINE ANALOG, AND A PLATINUM AGENT

USE OF JUMONJI C DEMETHYLASE INHIBITORS FOR THE TREATMENT AND PREVENTION OF CHEMOTHERAPY RESISTANCE AND RADIORESISTANCE IN CANCER

EXOSOMAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE

Composition comprising an algal proteoglycan extract and use thereof

ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF OVARIAN CANCER

IL-1BETA BINDING ANTIBODIES FOR USE IN TREATING CANCER

TREATMENT WITH ANTI-VEGF ANTIBODIES

COMBINATION THERAPIES FOR TREATING CANCER

CELL-PENETRATING CONJUGATE SYSTEMS

MONO- AND COMBINATION THERAPIES

CONTROLLED RELEASE OF SELF-EMBEDDING PARTICLES FOR LOCALIZED DRUG DELIVERY

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

DOSING REGIMEN OF ANTI-CD27 ANTIBODIES FOR TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME

METHODS OF TREATING HER2 POSITIVE CANCER WITH TUCATINIB IN COMBINATION WITH TRASTUZUMAB AND AN OXALIPLATIN-BASED CHEMOTHERAPY

Method For Treating Pancreatic Cancer

COMBINATION THERAPY

Use of amisulpride as an anti-emetic

Article for use with an apparatus for heating an aerosol generating agent

4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMINO]METHYL]PIPERIDIN-3-OL COMPOUNDS AND THEIR THERAPEUTIC USE

MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

Methods of treating ovarian cancer with hemp extract

Methods of treating endometrial cancer using hemp extract

METHODS OF TREATING HEAD AND NECK CANCERS WITH HEMP EXTRACT

GLYPICAN-3-SPECIFIC MODIFIED APTAMER AND USE THEREOF

METHODS FOR TREATING COLORECTAL AND METASTATIC COLORECTAL CANCERS

METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY

METHOD FOR TREATING CANCER USING A COMBINATION OF DNA DAMAGING AGENTS AND ATR INHIBITORS

7-Gene Prognostic and Predictive Assay for Non-Small Cell Lung Cancer in Formalin Fixed and Paraffin Embedded Samples

Composition and method for preventing, alleviating or treating cancer

MACROCYCLIC ULK1/2 INHIBITORS

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER

IMIDAZOLE-BASED SYNTHETIC LIPIDOIDS FOR IN VIVO MRNA DELIVERY INTO IMMUNE CELLS

[6R]-MTHF IN 5-FU BASED CHEMOTHERAPY OF RIGHT-SIDED COLORECTAL CANCER

[6R]-MTHF IN 5-FU BASED CHEMOTHERAPY OF BRAF- OR KRAS-MUTATED COLORECTAL CANCER

METHODS AND MATERIALS FOR TREATING CANCER

OXABICYCLOHEPTANES FOR TREATMENT OF SMALL CELL LUNG CANCER

FOAM COMPOSITIONS FOR THE TREATMENT OF CANCER

Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin

METHOD OF TREATING PANCREATIC CANCER

iRGD-ANALOGS AND RELATED THERAPEUTIC METHODS

N-(FURAN-2-YLMETHYL)-7H-PURIN-6-AMINE FOR TREATMENT OF CIRCADIAN RHYTHM DISEASES, DISORDERS AND DYSFUNCTIONS

POLYMORPHISMS AS PREDICTORS OF TREATMENT RESPONSE AND OVERALL SURVIVAL OF METASTATIC COLORECTAL CANCER

POLYMERIC NANOPARTICLES FOR ENHANCED CANCER TREATMENT

ANTI-CANCER COMPOSITIONS AND METHODS

METHODS OF CANCER TREATMENT BY DELIVERY OF siRNAs AGAINST NSD3

ANTIBODY AGAINST CLAUDIN 18A2 AND USE THEREOF

COMBINATION THERAPIES COMPRISING PANOBINOSTAT FOR THE TREATMENT OF CHOLANGIOCARCINOMA

ANTI-ICOS ANTIBODIES

Porous silicate/magnetic ferrite nanocarrier for combination anti-cancer therapeutic and antioxidant delivery

METHODS OF DETECTING A FUSION GENE ENCODING A NEOANTIGEN

USE OF IL-1BETA BINDING ANTIBODIES

COMPOSITIONS AND METHODS FOR TREATING CANCER

UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION

PHARMACEUTICAL COMPOSITION COMPRISING PRION PROTEIN-SPECIFIC ANTIBODY

ANTI-ICOS ANTIBODIES

COMPOSITIONS AND METHODS FOR DELIVERING CANNABINOIDS USING MICRONEEDLE DEVICES TO THE SKIN

COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF SOLID TUMORS

COMBINATION THERAPY OF CARBOPLATIN AND NAPI2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF OVARIAN CANCER

BRUSH PRODRUGS AND USES THEREOF

METHOD FOR INDUCING A SUSTAINED IMMUNE RESPONSE

MICROBEADS FOR EMBOLIZATION AND COMPOSITION FOR TREATING PROLIFERATIVE DISEASES

METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS

OKN-007 AS A THERAPEUTIC AGENT

COMPOSITIONS FOR THE TREATMENT OF NEUROPATHIC PAIN AND SENSITIZATION OF TUMORS TO CHEMOTHERAPIES

METHODS OF TREATING CANCER

COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES

COMBINATION THERAPY FOR CANCER

INHIBITING APE2 EXPRESSION IN A SUBJECT TREATED WITH A DRUG AGENT THAT CAUSES INCREASED APE2 EXPRESSION

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

METHODS FOR REDUCING TUMOR PROGRESSION AND FIBROSIS AND INCREASING ADAPTIVE IMMUNITY IN MALIGNANCIES

USE OF AMISULPRIDE AS AN ANTI-EMETIC

TARGETED CONJUGATES ENCAPSULATED IN PARTICLES AND FORMULATIONS THEREOF

MICROVASCULAR BLOOD FLOW DECREASING AGENT AND USE THEREOF

Platinum Complex Anti-Neoplastic Agents Comprising a Cannabinoid Ligand

METHOD FOR TREATMENT OF HEPATIC CANCER USING REIC/Dkk-3 GENE IN COMBINATION WITH ANTI-TUMOR AGENT

METHODS OF TREATING P53 MUTANT CANCERS USING OGDH INHIBITORS

PHARMACEUTICAL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF

RADIOPAQUE PARTICLE COMPOSITIONS AND USES THEREOF

5-heteroaryl-1H-pyrazol-3-amine derivative

Polyoxometalate complexes and pharmaceutical compositions

EZH2 INHIBITION IN COMBINATION THERAPIES FOR THE TREATMENT OF CANCERS

Pharmaceutical combination for the treatment of a cancer

MONOSACCHARIDE-TAGGED NANO-LIPOSOME DRUG DELIVERY SYSTEM, THE MANUFACTURE AND USE FOR DRUG TARGETING DELIVERY THEREOF

Methods of and compositions for reducing gene expression and/or activity

BENZOQUINONE DERIVATIVES FOR THE TREATMENT OF BLADDER CANCER